For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $46.73 in the prior trading day, PTC Therapeutics Inc (NASDAQ: PTCT) closed at $43.24, down -7.47%. In other words, the price has decreased by -$7.47 from its previous closing price. On the day, 1.31 million shares were traded. PTCT stock price reached its highest trading level at $46.16 during the session, while it also had its lowest trading level at $42.98.
Ratios:
Our goal is to gain a better understanding of PTCT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.31 and its Current Ratio is at 2.35.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on March 11, 2025, Upgraded its rating to Neutral and sets its target price to $55 from $41 previously.
On March 07, 2025, Scotiabank started tracking the stock assigning a Sector Perform rating and target price of $55.
Morgan Stanley Upgraded its Equal-Weight to Overweight on December 13, 2024, whereas the target price for the stock was revised from $45 to $67.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 02 ’25 when Golden Lee Scott sold 897 shares for $46.95 per share. The transaction valued at 42,114 led to the insider holds 75,997 shares of the business.
Golden Lee Scott bought 897 shares of PTCT for $42,117 on Apr 02 ’25. On Mar 17 ’25, another insider, Pauwels Eric, who serves as the CHIEF BUSINESS OFFICER of the company, sold 6,762 shares for $56.80 each. As a result, the insider received 384,067 and left with 72,640 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PTCT now has a Market Capitalization of 3410312960 and an Enterprise Value of 4727928320. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.23. Its current Enterprise Value per Revenue stands at 5.86 whereas that against EBITDA is -66.512.
Stock Price History:
The Beta on a monthly basis for PTCT is 0.54, which has changed by 0.6086309 over the last 52 weeks, in comparison to a change of -0.024663687 over the same period for the S&P500. Over the past 52 weeks, PTCT has reached a high of $58.38, while it has fallen to a 52-week low of $24.00. The 50-Day Moving Average of the stock is -15.40%, while the 200-Day Moving Average is calculated to be 3.73%.
Shares Statistics:
The stock has traded on average 830.48K shares per day over the past 3-months and 1223050 shares per day over the last 10 days, according to various share statistics. A total of 77.70M shares are outstanding, with a floating share count of 76.82M. Insiders hold about 2.60% of the company’s shares, while institutions hold 97.62% stake in the company. Shares short for PTCT as of 1741910400 were 4302958 with a Short Ratio of 5.18, compared to 1739491200 on 3696224. Therefore, it implies a Short% of Shares Outstanding of 4302958 and a Short% of Float of 8.38.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
